Korea Breast Milk Substitutes Market Size & Outlook, 2025-2033
Korea Breast Milk Substitutes Market Insights
- As highlighted in Deep Market Insights analysis, the Korea Breast Milk Substitutes Market, worth USD 140.86 Million in 2024, is forecasted to achieve USD 255.22 Million by 2033.
- The Korea market is anticipated to grow at a CAGR of 6.78% during the period 2026–2033.
- By 2024, Infant Formula represented the largest share of the Product Type market size.
- Infant Formula is expected to remain the key growth driver within Product Type, registering the fastest CAGR during the forecast period.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2024, Korea held 1.14% of the global Breast Milk Substitutes Market size.
- By 2033, United States is anticipated to capture the largest share of the global Breast Milk Substitutes Market.
- In Asia Pacific, China is expected to lead the regional Breast Milk Substitutes Market size by 2033.
- Singapore will remain the fastest-growing market in Asia Pacific, reaching USD 92.03 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 140.86 Million |
| Market Size In 2033 | USD 255.22 Million |
| Largest segment | Infant Formula |
| Units | Revenue in USD Million |
| CAGR | 6.78% (2025-2033) |
| Segmnetation Covered | |
| Product Type |
|
| Stage |
|
| Distribution Channel |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Korea Breast Milk Substitutes Market Product Type 2025-2033 (USD Million)
| Product Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infant Formula | XX.x | XX.x | XX.x | 60.78 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Follow On Formula | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialized Formula | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Organic Formula | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Breast Milk Substitutes Market Stage 2025-2033 (USD Million)
| Stage | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stage Zero | XX.x | XX.x | XX.x | 57.98 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Stage One | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Stage Two | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Stage Three | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Korea Breast Milk Substitutes Market Distribution Channel 2025-2033 (USD Million)
| Distribution Channel | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacies | XX.x | XX.x | XX.x | 56.77 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Supermarkets And Hypermarkets | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Online Retail | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty Stores | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.